Gerald Dorn
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$2.8MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $2.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 1, 2021 | NIH | STTR Phase II Mitofusin agonists to prevent Charcot-Marie-Tooth disease 2A | $2.0M | Mitochondria in Motion, Inc. with WASHINGTON UNIVERSITY |
| Sep 30, 2019 | NIH | STTR Phase I MITOFUSIN AGONISTS TO TREAT NEURODEGENERATIVE DISEASE | $557K | Mitochondria in Motion, Inc. with WASHINGTON UNIVERSITY |
| Sep 30, 2019 | NIH | STTR Phase I Mitofusin agonists to prevent Charcot-Marie-Tooth disease 2A | $254K | Mitochondria in Motion, Inc. with WASHINGTON UNIVERSITY |
Peer ranks
Federal funding#687
Awards as PI#822
Patents#273
Companies
- Mitochondria in Motion, Inc.Linked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.